Clinical Trial Update: Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Levonorgestrel/ethinyl estradiol for premenstrual syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Syndrome

Drugs mentioned

• Levonorgestrel/ethinyl estradiol (Levonorgestrel/ethinyl estradiol)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Premenstrual Syndrome | Phase 3 | Status: COMPLETED